Back

Comparison of percutaneous coronary intervention versus medication in dialysis patients with coronary artery disease

26 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Renal failure and bleeding in PCI patients Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Enmin Xie

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events.
Doctor S. Ikebe (Kumamoto, JP)
Abstract Slides Video
Presentation thumbnail
High bleeding risk mainly predicts non-access site bleeding events in the first month after percutaneous coronary intervention
Ms E. Woelders (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Parsimonious versus extensive score: can we simplify bleeding risk stratification after percutaneous coronary intervention without losing specificity?
Ms E. Woelders (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Platelet reactivity and activated clotting time predict haemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
Doctor B. Ramotowski (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Renal failure and bleeding in PCI patients

The Event

Event poster

ESC Congress 2023

26 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of percutaneous coronary intervention in chronic dialysis patients with acute myocardial infarction
thumbnail
Congress Presentation
Long-term clinical outcomes of hemodialysis patients with acute coronary syndrome undergoing primary percutaneous coronary intervention
thumbnail
Congress Presentation
Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with left main coronary artery disease and chronic kidney disease: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources